Public disclosures

De Witte Jan

Company insiders · Director · RESMED INC

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-20.Following & alerts
Reported transaction lines
3
Buy lines
0
Sell lines
1

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-113

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
De Witte Jan

Director · RESMED INC

RMD

RESMED INC

Equity grant or award
Filing details

SEC transaction code A

ResMed Common Stock · Direct ownership · Reported balance after transaction: 4881 · Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2027, or the annual meeting of stockholders in the year following the grant date.

2026-11-192026-11-20

1,109 shares/units

SEC 4
De Witte Jan

Director · RESMED INC

RMD

RESMED INC

Sell
Filing details

SEC transaction code S

ResMed Common Stock · Direct ownership · Reported balance after transaction: 3772 · SEC code covers open-market or private transactions · The transaction was conducted under a Rule 10b5-1 plan adopted August 19, 2026.

2026-11-172026-11-18

≈ $101,673.00

429 shares/units

SEC 4
De Witte Jan

Director · RESMED INC

RMD

RESMED INC

Other transaction
Filing details

SEC transaction code F

ResMed Common Stock · Direct ownership · Reported balance after transaction: 4201 · Securities delivered or withheld for tax or exercise payment · Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2025.

2026-11-112026-11-13

59.981 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement